Stem cell maintenance requires a specific microenvironment. Hematopoietic stem cells (HSCs) are mainly maintained by the endosteal osteoblast (OB) niche, which provides a quiescent HSC microenvironment, and the vascular niche, which regulates the proliferation, differentiation, and mobilization of HSCs. The systemic administration of FGF2 failed to induce normal hematopoiesis in bone marrow (BM) by reducing SDF-1, an important factor for hematopoiesis. Interestingly, SDF-1 levels were decreased in the OBs, but increased in vascular endothelial C166 cells when FGF2 was administered. We hypothesized that FGF2 induces changes in HSC migration from BM; therefore, we investigated FGF2-induced factors of HSC migration by a microarray chip. We searched the genes that were decreased in primary OBs, but increased in C166 cells upon FGF2 treatment. We confirmed selected genes that function in the extracellular region and identified the CXCR2-related chemokine candidate LIX/Cxcl5. A chemotaxis assay showed that CXCL5 induced the migration of HSCs (CD34−/lowLSK). Our data suggest that the differential regulation of the chemokine CXCL5 between OBs and endothelial cells upon FGF2 treatment is involved in HSC mobilization from the OB niche or BM to peripheral blood.
Get full access to this article
View all access options for this article.
References
1.
ZhangJ, NiuC, YeL, HuangH, HeX, TongWG, RossJ, HaugJ, JohnsonTet al. 2003. Identification of the haematopoietic stem cell niche and control of the niche size. Nature, 425:836–841.
ThisseB, ThisseC. 2005. Functions and regulations of fibroblast growth factor signaling during embryonic development. Dev Biol, 287:390–402.
8.
NguyenM, WatanabeH, BudsonAE, RichieJP, HayesDF, FolkmanJ. 1994. Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J Natl Cancer Inst, 86:356–361.
9.
AiutiA, WebbIJ, BleulC, SpringerT, Gutierrez-RamosJC. 1997. The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J Exp Med, 185:111–120.
10.
LatailladeJJ, ClayD, DupuyC, RigalS, JasminC, BourinP, Le Bousse-KerdilesMC. 2000. Chemokine SDF-1 enhances circulating CD34(+) cell proliferation in synergy with cytokines: possible role in progenitor survival. Blood, 95:756–768.
ChittetiBR, ChengYH, StreicherDA, Rodriguez-RodriguezS, CarlessoN, SrourEF, KacenaMA. Osteoblast lineage cells expressing high levels of Runx2 enhance hematopoietic progenitor cell proliferation and function. J Cell Biochem, 111:284–294.
17.
NilssonSK, JohnstonHM, WhittyGA, WilliamsB, WebbRJ, DenhardtDT, BertoncelloI, BendallLJ, SimmonsPJ, HaylockDN. 2005. Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells. Blood, 106:1232–1239.
18.
StierS, KoY, ForkertR, LutzC, NeuhausT, GrunewaldE, ChengT, DombkowskiD, CalviLM, RittlingSR, ScaddenDT. 2005. Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size. J Exp Med, 201:1781–1791.
19.
NakayamaT, MutsugaN, TosatoG. 2007. Effect of fibroblast growth factor 2 on stromal cell-derived factor 1 production by bone marrow stromal cells and hematopoiesis. J Natl Cancer Inst, 99:223–235.
20.
LevesqueJP, HendyJ, TakamatsuY, SimmonsPJ, BendallLJ. 2003. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest, 111:187–196.
21.
PelusLM, HorowitzD, CooperSC, KingAG. 2002. Peripheral blood stem cell mobilization. A role for CXC chemokines. Crit Rev Oncol Hematol, 43:257–275.
22.
NakayamaT, MutsugaN, TosatoG. 2007. FGF2 posttranscriptionally down-regulates expression of SDF1 in bone marrow stromal cells through FGFR1 IIIc. Blood, 109:1363–1372.
23.
YoonKA, ChaeYM, ChoJY. 2009. FGF2 stimulates SDF-1 expression through the Erm transcription factor in Sertoli cells. J Cell Physiol, 220:245–256.
24.
MurphyPM. 1996. Chemokine receptors: structure, function and role in microbial pathogenesis. Cytokine Growth Factor Rev, 7:47–64.
25.
KobayashiY. 2006. Neutrophil infiltration and chemokines. Crit Rev Immunol, 26:307–316.
26.
WrightDE, BowmanEP, WagersAJ, ButcherEC, WeissmanIL. 2002. Hematopoietic stem cells are uniquely selective in their migratory response to chemokines. J Exp Med, 195:1145–1154.
27.
ChoongML, YongYP, TanAC, LuoB, LodishHF. 2004. LIX: a chemokine with a role in hematopoietic stem cells maintenance. Cytokine, 25:239–245.
28.
YinT, LiL. 2006. The stem cell niches in bone. J Clin Invest, 116:1195–1201.
29.
ter HuurneM, FigdorCG, TorensmaR. Hematopoietic stem cells are coordinated by the molecular cues of the endosteal niche. Stem Cells Dev, 19:1131–1141.
30.
KunisakiY, FrenettePS. 2012. The secrets of the bone marrow niche: Enigmatic niche brings challenge for HSC expansion. Nat Med, 18:864–865.
31.
ChittetiBR, ChengYH, PoteatB, Rodriguez-RodriguezS, GoebelWS, CarlessoN, KacenaMA, SrourEF. 2010. Impact of interactions of cellular components of the bone marrow microenvironment on hematopoietic stem and progenitor cell function. Blood, 115:3239–3248.
32.
ChengYH, ChittetiBR, StreicherDA, MorganJA, Rodriguez-RodriguezS, CarlessoN, SrourEF, KacenaMA. 2011. Impact of maturational status on the ability of osteoblasts to enhance the hematopoietic function of stem and progenitor cells. J Bone Miner Res, 26:1111–1121.
33.
Mendez-FerrerS, MichurinaTV, FerraroF, MazloomAR, MacarthurBD, LiraSA, ScaddenDT, Ma'ayanA, EnikolopovGN, FrenettePS. 2010. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature, 466:829–834.
34.
NakamuraY, AraiF, IwasakiH, HosokawaK, KobayashiI, GomeiY, MatsumotoY, YoshiharaH, SudaT. 2010. Isolation and characterization of endosteal niche cell populations that regulate hematopoietic stem cells. Blood, 116:1422–1432.
WangSJ, GreerP, AuerbachR. 1996. Isolation and propagation of yolk-sac-derived endothelial cells from a hypervascular transgenic mouse expressing a gain-of-function fps/fes proto-oncogene. In Vitro Cell Dev Biol Anim, 32:292–299.
37.
LuLS, WangSJ, AuerbachR. 1996. In vitro and in vivo differentiation into B cells, T cells, and myeloid cells of primitive yolk sac hematopoietic precursor cells expanded >100-fold by coculture with a clonal yolk sac endothelial cell line. Proc Natl Acad Sci U S A, 93:14782–14787.
38.
O'ConnellK, LandmanG, FarmerE, EdidinM. 1991. Endothelial cells transformed by SV40 T antigen cause Kaposi's sarcomalike tumors in nude mice. Am J Pathol, 139:743–749.
39.
O'ConnellKA, EdidinM. 1990. A mouse lymphoid endothelial cell line immortalized by simian virus 40 binds lymphocytes and retains functional characteristics of normal endothelial cells. J Immunol, 144:521–525.
40.
O'ConnellKA, RudmannAA. 1993. Cloned spindle and epithelioid cells from murine Kaposi's sarcoma-like tumors are of endothelial origin. J Invest Dermatol, 100:742–745.
41.
BastakiM, NelliEE, Dell'EraP, RusnatiM, Molinari-TosattiMP, ParoliniS, AuerbachR, RucoLP, PossatiL, PrestaM. 1997. Basic fibroblast growth factor-induced angiogenic phenotype in mouse endothelium. A study of aortic and microvascular endothelial cell lines. Arterioscler Thromb Vasc Biol, 17:454–464.
42.
SalvucciO, YaoL, VillalbaS, SajewiczA, PittalugaS, TosatoG. 2002. Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1. Blood, 99:2703–2711.
43.
PonomaryovT, PeledA, PetitI, TaichmanRS, HablerL, SandbankJ, Arenzana-SeisdedosF, MagerusA, CaruzAet al. 2000. Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function. J Clin Invest, 106:1331–1339.
44.
PeledA, GrabovskyV, HablerL, SandbankJ, Arenzana-SeisdedosF, PetitI, Ben-HurH, LapidotT, AlonR. 1999. The chemokine SDF-1 stimulates integrin-mediated arrest of CD34(+) cells on vascular endothelium under shear flow. J Clin Invest, 104:1199–1211.
45.
LevesqueJP, WinklerIG. 2008. Mobilization of hematopoietic stem cells: state of the art. Curr Opin Organ Transplant, 13:53–58.
46.
KortesidisA, ZannettinoA, IsenmannS, ShiS, LapidotT, GronthosS. 2005. Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells. Blood, 105:3793–3801.
47.
ItkinT, LudinA, GradusB, Gur-CohenS, KalinkovichA, SchajnovitzA, OvadyaY, KolletO, CanaaniJet al. 2012. FGF-2 expands murine hematopoietic stem and progenitor cells via proliferation of stromal cells, c-Kit activation and CXCL12 downregulation. Blood[Epub ahead of print];10.1182/blood-2011-11-394692.
48.
TzengYS, LiH, KangYL, ChenWC, ChengWC, LaiDM. Loss of Cxcl12/Sdf-1 in adult mice decreases the quiescent state of hematopoietic stem/progenitor cells and alters the pattern of hematopoietic regeneration after myelosuppression. Blood, 117:429–439.
49.
KimKA, WagleM, TranK, ZhanX, DixonMA, LiuS, GrosD, KorverW, YonkovichSet al. 2008. R-Spondin family members regulate the Wnt pathway by a common mechanism. Mol Biol Cell, 19:2588–2596.
EashKJ, GreenbaumAM, GopalanPK, LinkDC. 2010. CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow. J Clin Invest, 120:2423–2431.
54.
TefferiA. 2000. Myelofibrosis with myeloid metaplasia. N Engl J Med, 342:1255–1265.
55.
ThieleJ, BraeckelC, WagnerS, FaliniB, DienemannD, SteinH, FischerR. 1992. Macrophages in normal human bone marrow and in chronic myeloproliferative disorders: an immunohistochemical and morphometric study by a new monoclonal antibody (PG-M1) on trephine biopsies. Virchows Arch A Pathol Anat Histopathol, 421:33–39.
56.
MesaRA, HansonCA, RajkumarSV, SchroederG, TefferiA. 2000. Evaluation and clinical correlations of bone marrow angiogenesis in myelofibrosis with myeloid metaplasia. Blood, 96:3374–3380.
57.
GuptaRR, YooDJ, HebertC, NigerC, StainsJP. 2010. Induction of an osteocyte-like phenotype by fibroblast growth factor-2. Biochem Biophys Res Commun, 402:258–264.
58.
XiaoL, LiuP, LiX, DoetschmanT, CoffinJD, DrissiH, HurleyMM. 2009. Exported 18-kDa isoform of fibroblast growth factor-2 is a critical determinant of bone mass in mice. J Biol Chem, 284:3170–3182.
59.
MonteroA, OkadaY, TomitaM, ItoM, TsurukamiH, NakamuraT, DoetschmanT, CoffinJD, HurleyMM. 2000. Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. J Clin Invest, 105:1085–1093.
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
